2'H-Androst-2-烯[3,2-c]吡唑-17-醇,17-甲基-,(5a,17b)-（CAS 302-96-5）：分子式 C21H32N2O、分子量 328.5。
| CAS号 | 302-96-5 |
|---|---|
| 分子式 | C21H32N2O |
| 分子量 | 328.5 |
| 熔点 | 229.8-242.0 °C |
| LogP | 4.5 |
| 应用领域 | Uses: MEDICATION (VET)、MEDICATION、Treatment of hereditary angioedema、Former、Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients、Pharmaceuticals -> Animal Drugs -> Approved in Taiwan、Methods of Manufacturing: Manson、US 3030358 (1962 to Sterling Drug).、17-Methyl-5alpha-androstan-17beta-ol-3-one is converted into its 2-formyl derivative which is then condensed with hydrazine hydrate.、Formulations、Preparations: Stanozolol、NF、Winstrol、tablets: 2 mg、From Table、General Manufacturing Information: ...Introduced primarily for use as anabolic agents with expectation that they would be relatively less androgenic than testosterone & its close relatives. None is free of androgenic activity in man、& in many instances androgenicity is much greater than results of animal tests had predicted.、Anabolic Steroids、Bioassay for anabolic potency.、Androgens & Anabolic steroids、Sanofi ... production suspended in October、2002、Discontinued、For more General Manufacturing Information (Complete) data for STANOZOLOL (7 total)、please visit the HSDB record page. |
登记用途：Uses: MEDICATION (VET)、MEDICATION、Treatment of hereditary angioedema、Former、Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients、Pharmaceuticals -> Animal Drugs -> Approved in Taiwan、Methods of Manufacturing: Manson、US 3030358 (1962 to Sterling Drug).、17-Methyl-5alpha-androstan-17beta-ol-3-one is converted into its 2-formyl derivative which is then condensed with hydrazine hydrate.、Formulations、Preparations: Stanozolol、NF、Winstrol、tablets: 2 mg、From Table、General Manufacturing Information: ...Introduced primarily for use as anabolic agents with expectation that they would be relatively less androgenic than testosterone & its close relatives. None is free of androgenic activity in man、& in many instances androgenicity is much greater than results of animal tests had predicted.、Anabolic Steroids、Bioassay for anabolic potency.、Androgens & Anabolic steroids、Sanofi ... production suspended in October、2002、Discontinued、For more General Manufacturing Information (Complete) data for STANOZOLOL (7 total)、please visit the HSDB record page.。
2'H-Androst-2-烯[3,2-c]吡唑-17-醇,17-甲基-,(5a,17b)- 是一种化工化合物，登记 CAS 号为 302-96-5，分子式 C21H32N2O（分子量 328.5）。
登记 CAS 号：302-96-5
其分子式 C21H32N2O 由 21 个碳、32 个氢、2 个氮、1 个氧 组成。
别名/同义词：2'H-Androst-2-烯[3,2-c]吡唑-17-醇,17-甲基-,(5a,17b)- · 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-
2'H-Androst-2-烯[3,2-c]吡唑-17-醇,17-甲基-,(5a,17b)- 的 CAS 登记号为 302-96-5。
分子式 C21H32N2O，分子量 328.5。
别名/同义词：2'H-Androst-2-烯[3,2-c]吡唑-17-醇,17-甲基-,(5a,17b)-、2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-。
登记用途：Uses: MEDICATION (VET)、MEDICATION、Treatment of hereditary angioedema、Former、Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients、Pharmaceuticals -> Animal Drugs -> Approved in Taiwan、Methods of Manufacturing: Manson、US 3030358 (1962 to Sterling Drug).、17-Methyl-5alpha-androstan-17beta-ol-3-one is converted into its 2-formyl derivative which is then condensed with hydrazine hydrate.、Formulations、Preparations: Stanozolol、NF、Winstrol、tablets: 2 mg、From Table、General Manufacturing Information: ...Introduced primarily for use as anabolic agents with expectation that they would be relatively less androgenic than testosterone & its close relatives. None is free of androgenic activity in man、& in many instances androgenicity is much greater than results of animal tests had predicted.、Anabolic Steroids、Bioassay for anabolic potency.、Androgens & Anabolic steroids、Sanofi ... production suspended in October、2002、Discontinued、For more General Manufacturing Information (Complete) data for STANOZOLOL (7 total)、please visit the HSDB record page.。
2'H-Androst-2-烯[3,2-c]吡唑-17-醇,17-甲基-,(5a,17b)-（CAS 302-96-5）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 302-96-5 |
|---|---|
| PubChem CID | 25249 |
| Molecular formula | C21H32N2O |
| IUPAC name | (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol |
| UNII (FDA) | 4R1VB9P8V3 |
| Molecular Weight | 328.5 |
|---|---|
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 328.251463648 |
| Monoisotopic Mass | 328.251463648 |
| Topological Polar Surface Area | 48.9 |
| Heavy Atom Count | 24 |
| Melting Point | 229.8-242.0 °C |
|---|
stanozolol; Winstrol; Androstanazole; 10418-03-8; Androstanazol; Stromba; Stanazolol; Tevabolin; Winstrol Depot; Strombaject; Estazol; Winstrol V; Estanozolol; Winstroid; Stanozololum; WIN 14833
| Reported hazard statements | H361 (95.2%) |
|---|
H361 (95.2%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)- · CAS 302-96-5 · C21H32N2O. UNII 4R1VB9P8V3. Melting Point: 229.8-242.0 °C.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-